These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 38346162)
1. A methylation-phosphorylation switch controls EZH2 stability and hematopoiesis. Guo P; Lim RC; Rajawasam K; Trinh T; Sun H; Zhang H Elife; 2024 Feb; 13():. PubMed ID: 38346162 [TBL] [Abstract][Full Text] [Related]
2. Distinct Stimulatory Mechanisms Regulate the Catalytic Activity of Polycomb Repressive Complex 2. Lee CH; Holder M; Grau D; Saldaña-Meyer R; Yu JR; Ganai RA; Zhang J; Wang M; LeRoy G; Dobenecker MW; Reinberg D; Armache KJ Mol Cell; 2018 May; 70(3):435-448.e5. PubMed ID: 29681498 [TBL] [Abstract][Full Text] [Related]
3. EZH2 variants differentially regulate polycomb repressive complex 2 in histone methylation and cell differentiation. Mu W; Starmer J; Yee D; Magnuson T Epigenetics Chromatin; 2018 Dec; 11(1):71. PubMed ID: 30522506 [TBL] [Abstract][Full Text] [Related]
4. Regulation of histone methylation by automethylation of PRC2. Wang X; Long Y; Paucek RD; Gooding AR; Lee T; Burdorf RM; Cech TR Genes Dev; 2019 Oct; 33(19-20):1416-1427. PubMed ID: 31488576 [TBL] [Abstract][Full Text] [Related]
5. The deletion of the protein phosphatase 1 regulator NIPP1 in testis causes hyperphosphorylation and degradation of the histone methyltransferase EZH2. Ferreira M; Verbinnen I; Fardilha M; Van Eynde A; Bollen M J Biol Chem; 2018 Nov; 293(47):18031-18039. PubMed ID: 30305391 [TBL] [Abstract][Full Text] [Related]
6. The role of EZH1 and EZH2 in development and cancer. Lee SH; Li Y; Kim H; Eum S; Park K; Lee CH BMB Rep; 2022 Dec; 55(12):595-601. PubMed ID: 36476271 [TBL] [Abstract][Full Text] [Related]
7. Proteolysis of methylated SOX2 protein is regulated by L3MBTL3 and CRL4 Zhang C; Leng F; Saxena L; Hoang N; Yu J; Alejo S; Lee L; Qi D; Lu F; Sun H; Zhang H J Biol Chem; 2019 Jan; 294(2):476-489. PubMed ID: 30442713 [TBL] [Abstract][Full Text] [Related]
8. EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency. Shen X; Liu Y; Hsu YJ; Fujiwara Y; Kim J; Mao X; Yuan GC; Orkin SH Mol Cell; 2008 Nov; 32(4):491-502. PubMed ID: 19026780 [TBL] [Abstract][Full Text] [Related]
9. Polycomb Repressive Complex 2 in Oncology. Guo Y; Yu Y; Wang GG Cancer Treat Res; 2023; 190():273-320. PubMed ID: 38113005 [TBL] [Abstract][Full Text] [Related]
10. Dissecting the role of H3K27 acetylation and methylation in PRC2 mediated control of cellular identity. Lavarone E; Barbieri CM; Pasini D Nat Commun; 2019 Apr; 10(1):1679. PubMed ID: 30976011 [TBL] [Abstract][Full Text] [Related]
11. Full methylation of H3K27 by PRC2 is dispensable for initial embryoid body formation but required to maintain differentiated cell identity. Miller SA; Damle M; Kim J; Kingston RE Development; 2021 Apr; 148(7):. PubMed ID: 33688077 [TBL] [Abstract][Full Text] [Related]
12. CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells. Wei Y; Chen YH; Li LY; Lang J; Yeh SP; Shi B; Yang CC; Yang JY; Lin CY; Lai CC; Hung MC Nat Cell Biol; 2011 Jan; 13(1):87-94. PubMed ID: 21131960 [TBL] [Abstract][Full Text] [Related]
13. EZH2 mutations in follicular lymphoma distort H3K27me3 profiles and alter transcriptional responses to PRC2 inhibition. Romero P; Richart L; Aflaki S; Petitalot A; Burton M; Michaud A; Masliah-Planchon J; Kuhnowski F; Le Cam S; Baliñas-Gavira C; Méaudre C; Luscan A; Hamza A; Legoix P; Vincent-Salomon A; Wassef M; Holoch D; Margueron R Nat Commun; 2024 Apr; 15(1):3452. PubMed ID: 38658543 [TBL] [Abstract][Full Text] [Related]
14. EZH2 W113C is a gain-of-function mutation in B-cell lymphoma enabling both PRC2 methyltransferase activation and tazemetostat resistance. Chu L; Tan D; Zhu M; Qu Y; Ma X; Song BL; Qi W J Biol Chem; 2023 Apr; 299(4):103073. PubMed ID: 36858198 [TBL] [Abstract][Full Text] [Related]
15. PGC7 regulates H3K27me3 modification by inhibiting the interaction of YY1 with PRC2. Hao W; Huang C; Liu D; Xu H; Liu Y; Guan Y; Chen B; Guo Z Am J Physiol Cell Physiol; 2023 Jul; 325(1):C286-C299. PubMed ID: 37306391 [TBL] [Abstract][Full Text] [Related]
16. EZH2 has a non-catalytic and PRC2-independent role in stabilizing DDB2 to promote nucleotide excision repair. Koyen AE; Madden MZ; Park D; Minten EV; Kapoor-Vazirani P; Werner E; Pfister NT; Haji-Seyed-Javadi R; Zhang H; Xu J; Deng N; Duong DM; Pecen TJ; Frazier Z; Nagel ZD; Lazaro JB; Mouw KW; Seyfried NT; Moreno CS; Owonikoko TK; Deng X; Yu DS Oncogene; 2020 Jun; 39(25):4798-4813. PubMed ID: 32457468 [TBL] [Abstract][Full Text] [Related]
17. Dependency on the polycomb gene Ezh2 distinguishes fetal from adult hematopoietic stem cells. Mochizuki-Kashio M; Mishima Y; Miyagi S; Negishi M; Saraya A; Konuma T; Shinga J; Koseki H; Iwama A Blood; 2011 Dec; 118(25):6553-61. PubMed ID: 22042701 [TBL] [Abstract][Full Text] [Related]
18. The roles of EZH2 in cancer and its inhibitors. Liu Y; Yang Q Med Oncol; 2023 May; 40(6):167. PubMed ID: 37148376 [TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function. Wan L; Xu K; Wei Y; Zhang J; Han T; Fry C; Zhang Z; Wang YV; Huang L; Yuan M; Xia W; Chang WC; Huang WC; Liu CL; Chang YC; Liu J; Wu Y; Jin VX; Dai X; Guo J; Liu J; Jiang S; Li J; Asara JM; Brown M; Hung MC; Wei W Mol Cell; 2018 Jan; 69(2):279-291.e5. PubMed ID: 29351847 [TBL] [Abstract][Full Text] [Related]
20. Targeting EZH2 and PRC2 dependence as novel anticancer therapy. Xu B; Konze KD; Jin J; Wang GG Exp Hematol; 2015 Aug; 43(8):698-712. PubMed ID: 26027790 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]